We are live on
!
Find out more
GC
Guggenheim Capital Portfolio holdings
AUM
$12.9B
1-Year Est. Return
27.3%
This Fund
S&P 500
This Quarter
Est. Return
+4.47%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+359.15%
AUM
$15B
AUM Growth
-$26B
(-63%)
Cap. Flow
-$26.2B
Cap. Flow
% of AUM
-175.02%
Top 10 Holdings %
Top 10 Hldgs %
16.62%
Holding
2,824
New
59
Increased
423
Reduced
1,872
Closed
463
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$24.9M |
| 2 |
Viatris
VTRS
|
+$22.8M |
| 3 |
Accenture
ACN
|
+$17.8M |
| 4 |
Seagate
STX
|
+$14.1M |
| 5 |
SHPG
Shire pic
SHPG
|
+$11.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$141M |
| 2 |
Meta Platforms (Facebook)
META
|
+$109M |
| 3 |
Adobe
ADBE
|
+$107M |
| 4 |
PayPal
PYPL
|
+$107M |
| 5 |
NVIDIA
NVDA
|
+$104M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.52% |
| 2 | Healthcare | 10.18% |
| 3 | Financials | 9.9% |
| 4 | Consumer Discretionary | 8.09% |
| 5 | Industrials | 7.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Healthpeak Properties
DOC
$15.1B
| $13.1M | 0.09% |
507,482
-1,310,917
| -72% | -$30.9M |
|
252
CME Group
CME
$96.3B
| $13.1M | 0.09% |
79,742
-224,360
| -74% | -$36.6M |
|
253
McKesson
MCK
$100B
| $13M | 0.09% |
97,723
-339,050
| -78% | -$49.6M |
|
254
Incyte
INCY
$24.2B
| $13M | 0.09% |
193,996
-530,150
| -73% | -$36.3M |
|
255
CBRE Group
CBRE
$42.5B
| $13M | 0.09% |
272,166
-1,189,432
| -81% | -$56.2M |
|
256
Moody's
MCO
$82.8B
| $13M | 0.09% |
76,080
-352,994
| -82% | -$59.7M |
|
|
ETW
257
Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund
ETW
$1.03B
| $13M | 0.09% |
1,099,258
-77,257
| -7% | -$906K |
|
258
Fortinet
FTNT
$119B
| $13M | 0.09% |
1,038,030
-1,041,480
| -50% | -$12.3M |
|
259
Molson Coors Class B
TAP
$7.79B
| $12.9M | 0.09% |
188,910
-765,348
| -80% | -$51M |
|
260
Microchip Technology
MCHP
$40.3B
| $12.7M | 0.09% |
279,902
-1,575,096
| -85% | -$73M |
|
261
TransDigm Group
TDG
$70.2B
| $12.7M | 0.08% |
36,776
-163,219
| -82% | -$53.6M |
|
262
Cousins Properties
CUZ
$5.19B
| $12.6M | 0.08% |
326,345
-87,492
| -21% | -$3.18M |
|
|
EOS
263
Eaton Vance Enhance Equity Income Fund II
EOS
$1.13B
| $12.6M | 0.08% |
748,821
-69,701
| -9% | -$1.18M |
|
264
Cardinal Health
CAH
$53.9B
| $12.6M | 0.08% |
257,604
-745,414
| -74% | -$42.3M |
|
265
Old Republic International
ORI
$10.5B
| $12.5M | 0.08% |
627,407
-110,454
| -15% | -$2.31M |
|
|
STI
266
DELISTED
SunTrust Banks, Inc.
STI
| $12.5M | 0.08% |
189,099
-601,677
| -76% | -$40.9M |
|
267
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
| $12.5M | 0.08% |
240,186
+13,430
| +6% | +$696K |
|
268
Travelers Companies
TRV
$78.1B
| $12.4M | 0.08% |
101,580
-317,643
| -76% | -$41.6M |
|
269
HF Sinclair
DINO
$16.3B
| $12.3M | 0.08% |
179,876
-80,880
| -31% | -$5.39M |
|
270
Diamondback Energy
FANG
$57.1B
| $12.2M | 0.08% |
92,978
-287
| -0.3% | -$35.6K |
|
271
Bread Financial
BFH
$4.37B
| $12.2M | 0.08% |
65,602
-248,094
| -79% | -$42.4M |
|
272
BioMarin Pharmaceuticals
BMRN
$11.6B
| $12.1M | 0.08% |
128,739
-3,663
| -3% | -$321K |
|
273
Cummins
CMI
$87.5B
| $12.1M | 0.08% |
91,178
-233,095
| -72% | -$34.9M |
|
274
iShares MBS ETF
MBB
$38.9B
| $12M | 0.08% |
115,486
+7,024
| +6% | +$729K |
|
275
Myriad Genetics
MYGN
$270M
| $12M | 0.08% |
320,876
-46,093
| -13% | -$1.56M |
|
Similar funds
TRSOTSOK
AIM
CII
AAMU
NMIFOAC
WANY
ACA
Guggenheim Capital's Q2 2018 Portfolio in Review
As of Q2 2018, Guggenheim Capital held 2,824 positions worth $15B, down 63% from $41B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Guggenheim Capital withdrew a net $26.2B in Q2 2018, closing 463 positions and reducing 1,872 holdings. Its most notable exit was CSRA Inc., an estimated $64.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Guggenheim Capital opened a new position in LyondellBasell Industries worth $24.9M.
- Guggenheim Capital's largest Q2 2018 buy was LyondellBasell Industries: 226,660 shares worth $24.9M.
- Guggenheim Capital added most to Shire pic in Q2 2018, an estimated $11.5M increase.
- Guggenheim Capital's biggest Q2 2018 reduction was Apple, cutting an estimated $141M.
- Guggenheim Capital fully exited CSRA Inc. in Q2 2018, selling an estimated $64.7M.
- Guggenheim Capital's ten largest holdings make up 17% of its $15B portfolio in Q2 2018.
- Guggenheim Capital opened 59 new positions and closed 463 in Q2 2018.
- Guggenheim Capital's portfolio value fell 63% quarter-over-quarter to $15B.
Based on Guggenheim Capital's 13F filing for Q2 2018, filed 14 Aug 2018.